Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ischemia Modified Albumin (IMA) Expression in the Male and Female Population

NCT02894671 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.

NCT NCT02894671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02894671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ischemia Modified Albumin (IMA) Expression in the Male and Female Population
Lead sponsor
Istituto Ortopedico Rizzoli
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
February 29, 2016
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group identification